Simbrinza: Medgend

Simbrinza FDA Approved Drugs

SIMBRINZA [Brimonidine Tartrate^{C₁₁H₁₀BrN₅C₄H₆O₆} : Brinzolamide^{C₁₂H₂₁N₃O₅S₃}]

0.2% : 1% (ophthalmic suspension/drops)

Novartis Pharms Corp^{Apr 19, 2013}

Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.